The following "How I Treat" sessions on myelodysplastic syndromes (MDS) took place at the 2018 ASH Meeting on Hematologic Malignancies. View the full schedule and program.
How I Incorporate Myeloid Mutation Testing to Treat MDS
Rafael Bejar, MD, PhD, University of California - San Diegoback to top
How Do You Treat Pancytopenia That Isn't MDS?
In this session, Dr. Amy DeZern will describe the difficulties in distinguishing various forms of marrow failure that are not myelodysplastic syndrome (MDS). She will discuss masqueraders and mimics of MDS which can cause pancytopenia that should be ruled prior to embarking on therapy for MDS. She will also review therapies for alternative diagnoses of pancytopenia.
Amy E. DeZern, MD, Johns Hopkins University
Amy E. DeZern, MD, is a faculty member in the Division of Hematologic Malignancies at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. She is an active clinical researcher in bone marrow failure syndromes, and her expertise is widely sought for consultations at all stages of these diseases. Dr. DeZern has expertise in diagnosis, clinical management, and treatment of patients with aplastic anemia and myelodysplastic syndromes as well as their clonal evolution to acute myeloid leukemia. Her current research interests include clinical trials of novel agents in myelodysplastic syndromes for newly diagnosed as well as refractory patients. Dr. DeZern also conducts trials of bone marrow transplantation in aplastic anemia.
back to top